Cravv
Natural health product licensed in Canada
- Licence holder
- ZPharm (9415149 Canada Inc.)
- NPN or DIN-HM
- 80072525
- Status
- Active licence
- Licence date
- 14 September 2016
- Revision date
- 5 June 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido-[1,2-alpha][1,5]diazocin-8-one Source : Cytisine | 1.5 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 4 Tous les jours ; maximum: 6 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in smoking cessation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use if you are pregnant or breastfeeding. If you have a gastrointestinal lesion/ulcer, cardiovascular, thyroid, liver or kidney disorders, or diabetes, consult a health care practitioner prior to use. Keep out of reach of children. Symptoms of an overdose include nausea, abdominal pain, vomiting, diarrhea, cold sweat, dizziness, disturbed hearing and vision, mental confusion, rapid heartbeat, difficulty breathing and marked weakness. Quitting smoking may cause changes in your mood (anxious, irritable, or depressed). If you experience changes in mood which do not improve or which worsen in the weeks following quitting, consult a health care practitioner.
- Effets indésirables connus
Sleep disturbances may occur.
Source
Official Health Canada record, licence 80072525
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.